Does DEXTROAMPHETAMINE Cause Product packaging quantity issue? 6 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product packaging quantity issue have been filed in association with DEXTROAMPHETAMINE (Zenzedi). This represents 0.3% of all adverse event reports for DEXTROAMPHETAMINE.
6
Reports of Product packaging quantity issue with DEXTROAMPHETAMINE
0.3%
of all DEXTROAMPHETAMINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From DEXTROAMPHETAMINE?
Of the 6 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEXTROAMPHETAMINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does DEXTROAMPHETAMINE Cause?
Drug ineffective (513)
Fatigue (170)
Anxiety (169)
Product substitution issue (163)
Headache (145)
Nausea (130)
Off label use (121)
Somnolence (110)
Feeling abnormal (108)
Product availability issue (106)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which DEXTROAMPHETAMINE Alternatives Have Lower Product packaging quantity issue Risk?
DEXTROAMPHETAMINE vs DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE
DEXTROAMPHETAMINE vs DEXTROMETHORPHAN
DEXTROAMPHETAMINE vs DEXTROMETHORPHAN HYDROBROMIDE
DEXTROAMPHETAMINE vs DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN
DEXTROAMPHETAMINE vs DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE